HDAC9 and acute myeloid leukemia: Clinically, low miR-199b correlates with myeloproliferation and poor overall survival in acute myeloid leukemia (AML), and its expression can be restored by histone deacetylases (HDAC) inhibitors, promoting cancer cell apoptosis [86].